HHT: A rare disease with a broad spectrum of clinical aspects

Current Pharmaceutical Design

Volumn 12, Issue 10, 2006, Pages 1217-1220

  Sabba C ^a,b   Gallitelli, M ^a,b   Pasculli, G ^a,b   Suppressa, P ^a,b   Resta, F ^b   Guastamachhia, ^b   Tafaro, E ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

HHT; Rare disease; Rendu Osler Weber; Telangiectases; Vascular malformations

Indexed keywords

ENDOGLIN;

ARTERIOVENOUS MALFORMATION; AUTOSOMAL DOMINANT DISORDER; BRAIN DISEASE; CHILDHOOD DISEASE; CHROMOSOME 12Q; CHROMOSOME 9Q; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LIVER DISEASE; LUNG DISEASE; MORBIDITY; MORTALITY; MUCOSA; PREVALENCE; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SKIN DISEASE; GENETICS;

HUMANS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 33744993215     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206776361219     Document Type: Review

References (42)

1. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32(3): 291-7.
2. Guttmacher AE, Marchuk DA, White RJ. Hereditary hemorrhagic telangiectasia N Engl J Med 1995; 33: 918-24.
3. Gallitelli M, Di Gennaro L, Suppressa P, Pasculli G, Sabbà C. Emergencies in Hereditary Haemorrhagic Telangiectasia. The Second Mediterranean Emergency Medicine Congress. Sitges/Barcelona, Spain, September 2003.
4. Strother CM, Newton TH. Percutaneous embolisation to control epistaxis in Rendu-Osler-Weber disease. Arch Otolaryngol 1976; 102(1): 58-60.
5. Pasculli G, Resta F, Guastamacchia E, Di Gennaro L, Suppressa P, Sabbà C. Health related quality of life in a rare disease. HHT or Rendu-Osler-Weber disease. Qual Life Res 2004; 13(10): 1715-23.
6. Braverman IM, Key A, Jacobson BS. Ultrastucture and three dimensional organisation of the telengiectases of hereditary hemorrhagic telengiectasia. J Invest Dermatol 1990; 95: 422-7.
7. Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984; 79(5): 363-7.
8. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology 1986; 91: 1079-83.
9. Porteous ME, Curtis A, Williams O, Marchuk D, Bhattacharya SS, Burn J. Genetic heterogeneity in hereditary haemorrhagic telangiectasia. J Med Genet 1994; 31: 925-6.
10. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J of Int Med 1999;245:31-9.
11. Saluja S, Henderson KJ, White RI Jr. Embolotherapy in the bronchial and pulmonary circulations. Radiol Clin North Am 2000; 38(2): 425-48, ix.
12. Wispelaere JF, Trigaux JP, Weynants P, Delos M, Coene BD. Systemic supply to a pulmonary arteriovenous malformation: potential explanation for recurrence. Cardiovasc Intervent Radiol 1996; 19(4): 285-7.
13. White RI Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988; 169(3): 663-9.
14. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32(3): 291-7.
15. Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 1985; 218(1): 105-9.
16. Lincoln MJ, Shigeoka JW. Pulmonary telangiectasia without hypoxemia. Chest 1988; 93(5): 1097-8.
17. Ference BA, Shannon TM, White RI Jr, Zawin M, Burdge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994; 106(5): 1387-90.
18. Martinez FJ, Villanueva AG, Pickering R, Becker FS, Smith DR. Spontaneous hemothorax. Report of 6 cases and review of the literature. Medicine (Baltimore), 1992; 71(6): 354-68.
19. Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JM. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM 1995; 88(12): 879-87.
20. Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH, et al. Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest 2000; 117(1): 31-8.
21. Press OW, Ramsey PG. Central nervous system infections associated with hereditary hemorrhagic telangiectasia. Am J Med 1984; 77(1): 86-92.
22. Dong SL, Reynolds SF, Steiner IP. Brain abscess in patients with hereditary hemorrhagic telangiectasia: case report and literature review. J Emerg Med 2001; 20(3): 247-51.
23. Lee DW, White RI Jr, Egglin TK, Pollak JS, Fayad PB, Wirth JA, et al. Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg 1997; 64(4): 930-40.
24. Shovlin C, Letarte M. Hereditary haemorrhagic telangiectasis and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54(8): 714-29.
25. Kjeldsen AD, Oxhoij H, Andersen PE, Elle B, Jacobsen JP, Vase P. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999; 116(2): 432-9.
26. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, et al. MR of hereditary hemorrhagic telangiectesia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 1998, 19(3): 477-84.
27. Matsubara S, Mandzia JL, ter Brugge K, Willinsky RA, Faughnan ME, Manzia JL. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 2000; 21(6): 1016-20.
28. Willinsky RA, Lasjaunias P, Terbrugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology 1990; 32(3): 207-10.
29. Easey AJ, Wallace JM, Huges GM, Jackson JE, Taylor, WJ, Shovlin CL Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22, 061 years of HHT patient life. J Neurol Neurosurg Psychiatry 2003; 74(6): 743-8.
30. Maher CO, Piepgras DG, Brown RD Jr, Friedman JA, Pollock BE. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32(4): 877-82.
31. Mandzia J, Henderson K, Faughnan M, White R Jr. Compelling reasons to screen brain in HHT. Stroke 2001; 32(12): 2957-8.
32. Stabile Ianora AA, Memeo M., Sabbà C, Cirulli A, Rotondo A, Angelelli G. Hereditary Hemorrhagic Teleangiectasia: multi-detector row helical CT assessment of liver involvment. Radiology 2004; 230(1): 250-9.
33. Bernard G, Mion F, Henry L, Plauchu H. Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological and hemodynamic studies of 11 cases. Gastroenterology 1993; 105: 482-7.
34. Fagel WJ, Perlberger R, Kauffmann RH. Portosystemic encephalopathy in hereditary hemorrhagic telangiectasia. Am J Med 1988; 85: 858-60.
35. Longo A, Cariati M, Gallitelli M, Sabbà C. Orthotopic liver transplantation in hereditary hemorrhagic telangiectasia. A long term follow up study on two patients. 5th HHT International Scientific Conference. Bonaire, Dutch Antilles, April 2003.
36. Larson, AM. Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 2003; 23 (2): 149-58.
37. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, et al. Liver disease in patient with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 343: 931-6.
38. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic Criteria for Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber-Syndrome). Am J Med Genet 2000; 9: 66-7.
39. Lastella P, Sabbà C, Lenato GM, Resta N, Lattanzi W, Gallitelli M, et al. Endoglin gene mutations and polymorphism in Italian patients with Hereditary Hemorrhagic Telangiectasia. Clin Genet 2003; 63 (6): 536-40.
40. Milionis HJ, Daskalopoulou SS, Elisaf M, Mikhailidis DP. The predictive value of lipid markers in vascular disease. Curr Pharm Des 2005; 11(17): 2209-24.
41. Robinson A, O'Neill S, Moran N. Novel integrin-specific targets for anti-platelet therapies. Curr Pharm Des 2004; 10(14): 1603-9.
42. Stenina OI. Regulation of vascular genes by glucose. Curr Pharm Des 2005; 11(18): 2367-81.